Mariner Wealth Advisors (NYC)’s Pfizer PFE Stock Holding History

Mariner Wealth Advisors (NYC)’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$205K	Buy	+6,212	New	+$197K	0.1%	54

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Mariner Wealth Advisors (NYC)'s PFE Position: Q1 2015 in Review

Mariner Wealth Advisors (NYC) opened a new position in Pfizer (PFE) in Q1 2015: 6,212 shares worth $205K. The stake represents 0.1% of the portfolio and ranks #54 among its holdings.

1,877 funds tracked by Wall St. Rank hold PFE as of Q1 2015.

Mariner Wealth Advisors (NYC) held 6,212 shares of Pfizer worth $205K as of Q1 2015.
Pfizer was a new Mariner Wealth Advisors (NYC) position in Q1 2015.
Pfizer made up 0.1% of Mariner Wealth Advisors (NYC)'s portfolio in Q1 2015, its #54 holding.
1,877 funds tracked by Wall St. Rank held Pfizer as of Q1 2015.

Based on Mariner Wealth Advisors (NYC)'s 13F filing for Q1 2015, filed 14 May 2015.